Cedron Jorge Andres 4
4 · Orthofix Medical Inc. · Filed Apr 20, 2026
Research Summary
AI-generated summary of this filing
Orthofix (OFIX) CLO Cedron Jorge Andres Sells 3,743 Shares
What Happened
Cedron Jorge Andres, the Chief Legal Officer (CLO) of Orthofix Medical Inc. (OFIX), sold 3,743 shares on 2026-04-16 at $12.82 per share for proceeds of $47,985. The sale was made to satisfy tax withholding obligations in connection with the settlement of restricted stock units (RSUs) and was executed pursuant to a pre-existing sell-to-cover arrangement; the reporting person did not exercise discretion in the sale.
Key Details
- Transaction date: 2026-04-16; Sale price: $12.82 per share; Shares sold: 3,743; Gross proceeds: $47,985.
- Transaction type/code: Sale (S) — open market or private sale.
- Purpose: Tax withholding on RSU settlement (sell-to-cover), per footnote F1; sale mandated by plan administrator.
- Footnote F2: Notes inclusion of 44,353 previously reported restricted stock units in the reported ownership disclosure.
- Filing: Form 4 filed 2026-04-20 for the 2026-04-16 transaction — appears timely (filed within required reporting window).
- Shares owned after the transaction: not specified in the provided excerpt; F2 indicates previously reported RSUs are included in beneficial ownership.
Context
Sell-to-cover transactions are routine tax-withholding sales tied to RSU settlements and generally reflect required tax handling rather than a discretionary view on the company. Sales (code S) are common for tax or liquidity reasons; purchases are typically considered more informative about insider sentiment. This filing documents a routine, non-discretionary sell-to-cover sale by the CLO.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-04-16$12.82/sh−3,743$47,985→ 59,006 total
Footnotes (2)
- [F1]Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.
- [F2]Includes 44,353 previously reported restricted stock units.